Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Innovation Pharmaceuticals Inc IPIX

Innovation Pharmaceuticals Inc. is a clinical stage pharmaceutical company developing therapies with anti-infective, oncology, anti-inflammatory and dermatology applications. The Company’s lead drug candidate, Brilacidin, is in a class of compounds called defensin-mimetics, small compounds that mimic the structure and function of defensins, also known as host defense peptides. The Company is... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (GREY:IPIX)

Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024

GlobeNewswire August 28, 2023

Innovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal Diseases

GlobeNewswire June 21, 2023

Innovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration Testing

GlobeNewswire June 5, 2023

Innovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature Communications

GlobeNewswire April 17, 2023

Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers

GlobeNewswire March 15, 2023

Innovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA Submission

GlobeNewswire February 23, 2023

Innovation Pharmaceuticals Announces BT BeaMedical Technologies and Shina Systems Ltd. Enter into a Definitive Strategic Development Agreement

GlobeNewswire January 9, 2023

Innovation Pharmaceuticals Reports New In Vivo Antifungal Data Showing Brilacidin's Potential for Treating Fungal Keratitis

GlobeNewswire December 13, 2022

Innovation Pharmaceuticals Announces BT BeaMedical Technologies Receives FDA Clearance for New Surgical Laser Family

GlobeNewswire November 28, 2022

Opinion & Analysis (GREY:IPIX)

No current opinion is available.

Bullboard Posts (GREY:IPIX)

TGIFF 1933 Industries - Nevada dispensaries everywhere...

TGIFF – 1933 Ind. 2021 AMA Dispensary Drops in Las Vegas and Nevada Deliveries of flower, concentrates, badder, diamonds, exotics...
INVESTigator1 - May 9, 2021

Innovation + WPD Pharmaceuticals

Do you believe in a fusion of Innovation and WPD Pharmaceuticals? Together they could beat the virus faster and bettter....
Blocky - January 10, 2021

News

State of the State... Brilacidin results, SI of 426 (far superior than first hoped for), Free Trials conducted at non-bias RBL's, and...
Brito1 - October 30, 2020

latest News

WAKEFIELD, MA September 15, 2020 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (the Company), a clinical stage...
Brito1 - September 18, 2020

More great thoughts

Another great post, thanks to The poster Mo Thoughts on today's announcement: - Todays news is outstanding in that it will get...
Brito1 - September 15, 2020

Regarding todays news

Great Post by Fat Albert at the swamp: Anyone see a connection? Leo puts out a PR about Kevetrin's ability to arrest cell growth in...
Brito1 - September 15, 2020